1 min read|58 words
Breakthrough alert: Yale researchers have demonstrated a novel prime-and-pull vaccine approach that prevented genital herpes infection in preclinical animal models—marking potential progress on a condition affecting 1 in 6 people globally. The strategy enhances mucosal immunity at the infection site, addressing why previous vaccines failed. Human trials are the next critical step.
Read the full article on GMJ Newsroom →
Was this article helpful?
